| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The First Department of Medicine, Osaka University School of Medicine, Osaka 565, Japan
To clarify the role of mitogen-inducible cyclooxygenase (COX-2) in the development of malignant tumors, we investigated the effects of COX-2 inhibitors on the growth of gastric cancer xenografts in nude mice in vivo. MKN45 gastric cancer cells (5 × 106 cells/animal) that overexpress COX-2 were inoculated subcutaneously into athymic mice. NS-398, a specific COX-2 inhibitor, or indomethacin, a nonspecific COX-2 inhibitor, was administered orally to animals every day for 20 days. These drugs reduced the tumor volume significantly. Immunohistochemistry using bromodeoxyuridine, nick end labeling, and electron microscopy showed that NS-398 induced apoptosis in cancer cells in a dose-dependent manner and inhibited cancer cell replication slightly. Indomethacin also induced apoptosis and suppressed replication of tumor cells. There was a significant negative correlation between tumor volume and apoptotic cell number within the tumor. These results are consistent with the hypothesis that COX-2 inhibitors suppress growth of gastric cancer xenografts mainly by inducing apoptosis and suppressing replication of the neoplastic cells. It follows that COX-2 plays an important role in the development of gastric cancer.
nonsteroidal anti-inflammatory drugs; programmed cell death; prostaglandin; cell proliferation
This article has been cited by other articles:
|
|
 |
|
  M. Sovak, A. L. Seligson, M. Konas, M. Hajduch, M. Dolezal, M. Machala, and R. Nagourney Herbal Composition PC-SPES for Management of Prostate Cancer: Identification of Active Principles J Natl Cancer Inst, September 4, 2002; 94(17): 1275 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Subbaramaiah, L. Norton, W. Gerald, and A. J. Dannenberg Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer. EVIDENCE FOR INVOLVEMENT OF AP-1 AND PEA3 J. Biol. Chem., May 17, 2002; 277(21): 18649 - 18657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Subbaramaiah, P. A. Cole, and A. J. Dannenberg Retinoids and Carnosol Suppress Cyclooxygenase-2 Transcription by CREB-binding Protein/p300-dependent and -independent Mechanisms Cancer Res., May 1, 2002; 62(9): 2522 - 2530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Niki, T. Kohno, S. Iba, Y. Moriya, Y. Takahashi, M. Saito, A. Maeshima, T. Yamada, Y. Matsuno, M. Fukayama, et al. Frequent Co-Localization of Cox-2 and Laminin-5 {gamma}2 Chain at the Invasive Front of Early-Stage Lung Adenocarcinomas Am. J. Pathol., March 1, 2002; 160(3): 1129 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. I. Kim, Y. C. Lee, K. H. Lee, J. H. Han, C. Y. Chon, Y. M. Moon, J. K. Kang, and I. S. Park Effects of Nonsteroidal Anti-Inflammatory Drugs on Helicobacter pylori-Infected Gastric Mucosae of Mice: Apoptosis, Cell Proliferation, and Inflammatory Activity Infect. Immun., August 1, 2001; 69(8): 5056 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Saukkonen, O. Nieminen, B. van Rees, S. Vilkki, M. Harkonen, M. Juhola, J.-P. Mecklin, P. Sipponen, and A. Ristimaki Expression of Cyclooxygenase-2 in Dysplasia of the Stomach and in Intestinal-type Gastric Adenocarcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1923 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Hung, H.-C. Chang, M.-R. Pan, T.-H. Lee, and L.-Y. Chuang Induction of p27KIP1 as a Mechanism Underlying NS398-Induced Growth Inhibition in Human Lung Cancer Cells Mol. Pharmacol., April 13, 2001; 58(6): 1398 - 1403. [Abstract] [Full Text]
|
|
|
|
 |
|
 W.-H. Sun, S. Tsuji, M. Tsujii, E. S. Gunawan, N. Kawai, A. Kimura, Y. Kakiuchi, M. Yasumaru, H. Iijima, Y. Okuda, et al. Induction of Cyclooxygenase-2 in Rat Gastric Mucosa by Rebamipide, a Mucoprotective Agent J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 447 - 452. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Y. Sung, W. K. Leung, M. Y. Y. Go, K. F. To, A. S. L. Cheng, E. K. W. Ng, and F. K. L. Chan Cyclooxygenase-2 Expression in Helicobacter pylori-Associated Premalignant and Malignant Gastric Lesions Am. J. Pathol., September 1, 2000; 157(3): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujii, T. Matsura, M. Kai, H. Matsui, H. Kawasaki, and K. Yamada Mitochondrial Cytochrome c Release and Caspase-3-Like Protease Activation During Indomethacin-Induced Apoptosis in Rat Gastric Mucosal Cells Experimental Biology and Medicine, June 1, 2000; 224(2): 102 - 108. [Abstract] [Full Text]
|
|
|
|
|
|
K. Subbaramaiah, J. C. Hart, L. Norton, and A. J. Dannenberg Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2. EVIDENCE FOR INVOLVEMENT OF ERK1/2 AND p38 MITOGEN-ACTIVATED PROTEIN KINASE PATHWAYS J. Biol. Chem., May 12, 2000; 275(20): 14838 - 14845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gallo Re: Enhancement of Tumor Response to {gamma}-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme J Natl Cancer Inst, February 16, 2000; 92(4): 346 - 346. [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Coogan, L. Rosenberg, J. R. Palmer, B. L. Strom, A. G. Zauber, P. D. Stolley, and S. Shapiro Nonsteroidal Anti-Inflammatory Drugs and Risk of Digestive Cancers at Sites Other Than the Large Bowel Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 119 - 123. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kondo, H. Yamamoto, H. Nagano, J. Okami, Y. Ito, J. Shimizu, H. Eguchi, A. Miyamoto, K. Dono, K. Umeshita, et al. Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma Clin. Cancer Res., December 1, 1999; 5(12): 4005 - 4012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, S. G. Morham, R. Langenbach, and D. A. Young Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (NSAIDs) on Cyclooxygenase-null Embryo Fibroblasts J. Exp. Med., August 16, 1999; 190(4): 451 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, and A. B. West Myofibroblasts. II. Intestinal subepithelial myofibroblasts Am J Physiol Cell Physiol, August 1, 1999; 277(2): C183 - C201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Subbaramaiah, D. T. Lin, J. C. Hart, and A. J. Dannenberg Peroxisome Proliferator-activated Receptor gamma Ligands Suppress the Transcriptional Activation of Cyclooxygenase-2. EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1 AND CREB-BINDING PROTEIN/p300 J. Biol. Chem., April 6, 2001; 276(15): 12440 - 12448. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
